搜尋結果 Search results
品牌:「adi」約有 14855 項產品 / 頁數 496 - 495
品牌篩選:
名稱 | 規格 | 貨號 | 品牌 | 應用 |
---|---|---|---|---|
[Arg14,20,21, Leu16]-PACAP (1-27), amide, human, ovine, rat [His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-NH2; MW: 3213.7] | 1 mg | SP-101262-1 | ADI | |
[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat [His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-NH2; MW: 3555.10] | 1 mg | SP-101260-1 | ADI | |
[Arg0] Met-Enkephalin [Arg-Tyr-Gly-Gly-Phe-Met; MW: 729.86] | 5 mg | SP-88443-5 | ADI | |
[APLILSR] pPSA [Ala-Pro-Leu-Ile-Leu-Ser-Arg-Ile-Val-Gly-Gly-Trp-Glu-Cys-Glu-Lys; MW: 1771.12] | 5 mg | SP-88254-5 | ADI | |
[Ala9] Autocamtide 2; Autocamtide-2-Related Inhibitory Peptide [Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu; MW: 1497.7] | 5 mg | SP-102106-5 | ADI | |
[Ala9, 10, Lys11, 12] Glycogen Synthase (1-12) [Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys; MW: 1270.7] | 5 mg | SP-101522-5 | ADI | |
[Ala81]-MBP (74-85) [Gln-Lys-Ser-Gln-Arg-Ser-Gln-Ala-Glu-Asn-Pro-Val; MW: 1371.48] | 5 mg | SP-88008-5 | ADI | |
[Ala8]-Humanin, [Ala8}-HN, Shna [Met-Ala-Pro-Arg-Gly-Phe-Ser-Ala-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala; MW: 2655.23] | 1 mg | SP-87932-1 | ADI | |
[Ala5, β-Ala8]-Neurokinin A (4-10) [Asp-Ala-Phe-Val-β-Ala-Leu-Met-NH2; MW: 765] | 5 mg | SP-101110-5 | ADI | |
[Ala4]-MBP (1-11) [Ac-Ala-Ser-Gln-Ala-Arg-Pro-Ser-Gln-Arg-His-Gly; MW: 1236.32] | 5 mg | SP-88007-5 | ADI | |
[Ala31, Aib32]-Neuropeptide Y (NPY) (porcine) | 1 mg | SP-100062-1 | ADI | |
[Ala3, 11, 18, Nle7] Endothelin-1, human [Cys-Ser-Ala-Ser-Ser-Leu-Nle-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp; MW: 2349.78] | 1 mg | SP-88397-1 | ADI | |
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302)) [Met-His-Arg-Gln-Glu-Ala-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala; MW: 2600.12] | 1 mg | SP-102026-1 | ADI | |
[Ala2] Met-Enkephalin, amide [Tyr-Ala-Gly-Phe-Met-NH2; MW: 586.72] | 5 mg | SP-88442-5 | ADI | |
[Ala19]Glucagon-Like Peptide II (GLP-2/GLP2, Rat [H-His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH; MW: 3766.2] | 0.5 mg | SP-55287 | ADI | |
[Ala18] Endothelin-1, human [Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp; MW: 2451.94] | 1 mg | SP-88396-1 | ADI | |
[Ala144]-PLP (139-151) A144-PLP (139-151) [His-Ser-Leu-Gly-Lys-Ala-Leu-Gly-His-Pro-Asp-Lys-Phe; MW: 1406.62] | 5 mg | SP-86877-5 | ADI | |
[Ala13]-Apelin-13 [Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala; MW: 1474.76] | 5 mg | SP-88338-5 | ADI | |
[Ala11, D-Leu15]-Orexin B (human) | 1 mg | SP-100439-1 | ADI | |
[Ala11, 22, 28]-VIP (human, bovine, porcine, rat) [His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2; MW: 3160.72] | 1 mg | SP-76065-1 | ADI | |
[Ala1]-PAR-4 (1-6) amide (mouse) [Ala-Tyr-Pro-Gly-Lys-Phe-NH2; MW: 680.81] | 5 mg | SP-52774-5 | ADI | |
[Ala1]-PAR-4 (1-6) (mouse) [Ala-Tyr-Pro-Gly-Lys-Phe; MW: 681.80] | 5 mg | SP-53278-5 | ADI | |
[Ac-Cys4, DPhe7, Cys10] a-MSH (4-13), amide [Ac-Cys-Glu-His-D-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH2; MW: 1345.61] | 5 mg | SP-88491-5 | ADI | |
(PPPPNPPND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure | 1 mg | PPPP312-P | ADI | |
(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) control/blocking peptide | 100 ug | PPPP321-P | ADI | |
(PPPPNAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP) conjugated with BSA | 0.5 mg | PPPP321-BSA | ADI | |
(PAPPNAAND)3 peptide (repeat-sequence peptide of the P. berghei circumsporozoite protein, CSP), pure | 1 mg | PAPP311-P | ADI | |
(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide | 100 ug | NVDP41-P | ADI | |
(NVDP)4 peptide (minor repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) conjugated with BSA | 0.5 mg | NVDP41-BSA | ADI | |
(NANP)5 peptide (repeat-sequence peptide of the P. falciparum circumsporozoite protein, CSP) control/blocking peptide | 1 mg | NANP51-P | ADI |